Search results
Life360 Announces Pricing of U.S. Initial Public Offering
KOIN News 6 Portland· 2 days agoSan Francisco area-based Life360, Inc. ("Life360" or the "Company") today announced the pricing of its initial public offering in the U.S. (the "Offering ...
Waystar shares fall 2% in underwhelming Nasdaq debut
WHTC 1450 Holland· 6 hours ago(Reuters) -Shares of Waystar fell 2.3% below their initial public offering price in their Nasdaq Global Select Market debut on Friday ...
KindlyMD Announces Closing of $6.8 Million Initial Public Offering
Morningstar· 4 days ago(NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating...treatment plans ...
Life360 Launches 5.75M Share IPO
Investing.com· 5 days agoLife360 is offering 3,286,231 shares of common stock and the selling securityholders named in the prospectus are offering 2,463,769 shares of common...
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
InvestorPlace· 14 hours agoOne of the fastest ways to make money on the stock market is to gamble on short-term contrarian...
Tracking app company Life360 goes public
Fox Business via Yahoo Finance· 1 day agoLife360, Inc., a tech firm that helps people keep track of the whereabouts of their loved ones and belongings, made its public debut Thursday. The...
J&J-backed Rapport Therapeutics valued at $636.8 million in lukewarm debut
Reuters via AOL· 8 hours agoU.S. IPOs are seeing a rebound this year, after an almost two-year dry spell when high interest rates, market volatility and geopolitical turmoil marred investors' risk appetite. Among other ...
Illumina to spin off early cancer detection test maker Grail after ill-fated $8 billion acquisition...
The Business Journals· 2 days agoMore than three years after planning its own initial public offering, early cancer detection test...
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 4 hours agoJohnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, in a tepid debut for the early-stage therapy developer.
Healthcare payments firm Waystar shares fall 2% in tepid Nasdaq debut
StreetInsider· 4 hours agoBy Arasu Kannagi Basil and Echo Wang (Reuters) -Shares of Waystar fell 2.3% below their initial public offering price in their Nasdaq ...
